Clinical Trial Update: Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating vaccine therapy in combination with Rintatolimod and/or Sargramostim for HER2-positive breast cancer patients ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Male Breast Cancer
• Stage Iiia Breast Cancer
• Stage Iiib Breast Cancer
• Stage Iiic Breast Cancer

Drugs mentioned

• Rintatolimod (rintatolimod)
• sargramostim (sargramostim)
• vaccine therapy (unspecified)

Snippet

Sponsor: University of Washington | Conditions: HER2-positive Breast Cancer, Male Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED